Coave Therapeutics
Latest round
- Series B
Last raised
- Feb 2023
Total raised
- $43M
Investors
- 11
About Coave Therapeutics
Founded in 2014 in Paris, France, Coave Therapeutics SA develops innovative gene therapies targeting rare diseases. The leadership team includes CEO Christine Placet, with Rodolphe Clerval also playing a key role.Coave Therapeutics specializes in advanced gene therapies targeting rare ocular and central nervous system (CNS) diseases. Their primary focus is on their proprietary ALIGATER™ platform, which develops conjugated adeno-associated virus (coAAV) vectors for enhanced gene therapy delivery.Coave Therapeutics generates revenue through strategic partnerships and collaborations with pharmaceutical companies and research institutions. Their revenue model includes agreements for research and development milestones, licensing deals, and co-development partnerships, sharing risks and rewards in product development. Their flagship products, CTx-TFEB and CTx-PDE6b, are expected to drive future revenue through potential commercialization. Coave aims to enhance its offerings and reach a broader patient base as part of its growth strategy.
Who invested in Coave Therapeutics
11 investors across 4 rounds
See all investors in Coave Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Coave Therapeutics
Who invested in Coave Therapeutics?
Coave Therapeutics has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Coave Therapeutics raised?
Coave Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Coave Therapeutics last raise money?
Coave Therapeutics's most recent round on record is a Series B, in Feb 2023.
What does Coave Therapeutics do?
Founded in 2014 in Paris, France, Coave Therapeutics SA develops innovative gene therapies targeting rare diseases.
Where is Coave Therapeutics headquartered?
Coave Therapeutics is headquartered in Paris, France.
Which VCs invest in companies like Coave Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Coave Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Coave Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.